These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 16321824)

  • 41. Dendritic cell vaccination of patients with metastatic colorectal cancer.
    Burgdorf SK
    Dan Med Bull; 2010 Sep; 57(9):B4171. PubMed ID: 20816019
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Current vaccination strategies for the treatment of B-cell lymphoma and multiple myeloma.
    Hollander N
    Crit Rev Immunol; 2009; 29(5):399-418. PubMed ID: 20001888
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term idiotype vaccination combined with interleukin-12 (IL-12), or IL-12 and granulocyte macrophage colony-stimulating factor, in early-stage multiple myeloma patients.
    Hansson L; Abdalla AO; Moshfegh A; Choudhury A; Rabbani H; Nilsson B; Osterborg A; Mellstedt H
    Clin Cancer Res; 2007 Mar; 13(5):1503-10. PubMed ID: 17332295
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical results of the ID-KLH vaccination with local GM-CSF in patients with follicular lymphomas (published in Nature Med 1999; 5: 1171-1177) summary of the lecture by L. W. Kwak.
    Schumacher K
    J Cancer Res Clin Oncol; 2001 Oct; 127 Suppl 2():R10-3. PubMed ID: 11768618
    [No Abstract]   [Full Text] [Related]  

  • 45. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
    Ruffini PA; Neelapu SS; Kwak LW; Biragyn A
    Haematologica; 2002 Sep; 87(9):989-1001. PubMed ID: 12217812
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Deletion of idiotype (Id)-specific T cells in multiple myeloma.
    Bogen B; Schenck K; Munthe LA; Dembic Z
    Acta Oncol; 2000; 39(7):783-8. PubMed ID: 11145433
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transfer of idiotypic protein primed allogeneic marrow grafts elicits potent graft-versus-myeloma effects in mice.
    Zeis M; Steinmann J; Petrela E; Hartung G; Schmitz N; Uharek L
    Bone Marrow Transplant; 2001 Feb; 27(3):279-85. PubMed ID: 11277175
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vaccination with dendritic cell/tumor fusions following autologous stem cell transplant induces immunologic and clinical responses in multiple myeloma patients.
    Rosenblatt J; Avivi I; Vasir B; Uhl L; Munshi NC; Katz T; Dey BR; Somaiya P; Mills H; Campigotto F; Weller E; Joyce R; Levine JD; Tzachanis D; Richardson P; Laubach J; Raje N; Boussiotis V; Yuan YE; Bisharat L; Held V; Rowe J; Anderson K; Kufe D; Avigan D
    Clin Cancer Res; 2013 Jul; 19(13):3640-8. PubMed ID: 23685836
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prolonged idiotypic vaccination against follicular lymphoma.
    Inoges S; Lopez-Diaz de Cerio A; Zabalegui N; Soria E; Villanueva H; Panizo C; Rodriguez-Caballero A; Suarez L; Pastor F; Rodriguez-Calvillo M; Orfao A; Bendandi M
    Leuk Lymphoma; 2009 Jan; 50(1):47-53. PubMed ID: 19152172
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dendritic cell-based therapeutic vaccination against myeloma: vaccine formulation determines efficacy against light chain myeloma.
    Cohen S; Haimovich J; Hollander N
    J Immunol; 2009 Feb; 182(3):1667-73. PubMed ID: 19155516
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CpG or IFN-α are more potent adjuvants than GM-CSF to promote anti-tumor immunity following idiotype vaccine in multiple myeloma.
    Hong S; Qian J; Li H; Yang J; Lu Y; Zheng Y; Yi Q
    Cancer Immunol Immunother; 2012 Apr; 61(4):561-71. PubMed ID: 22002243
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Idiotype immunity (natural and vaccine-induced) in early stage multiple myeloma.
    Osterborg A; Henriksson L; Mellstedt H
    Acta Oncol; 2000; 39(7):797-800. PubMed ID: 11145435
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunotherapy in multiple myeloma: current strategies and future prospects.
    Yi Q
    Expert Rev Vaccines; 2003 Jun; 2(3):391-8. PubMed ID: 12903804
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Antitumor immune responses induced by idiotype-pulsed dendritic cells with cell-penetrating peptide vaccination in vivo].
    Chang JH; Shi YX; Zhiang XS; Jiang WQ; Guan ZZ
    Zhonghua Zhong Liu Za Zhi; 2007 Nov; 29(11):804-7. PubMed ID: 18396634
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunogenicity of a plasmid DNA vaccine encoding chimeric idiotype in patients with B-cell lymphoma.
    Timmerman JM; Singh G; Hermanson G; Hobart P; Czerwinski DK; Taidi B; Rajapaksa R; Caspar CB; Van Beckhoven A; Levy R
    Cancer Res; 2002 Oct; 62(20):5845-52. PubMed ID: 12384547
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tumor antigen immunization of sibling stem cell transplant donors in multiple myeloma.
    Neelapu SS; Munshi NC; Jagannath S; Watson TM; Pennington R; Reynolds C; Barlogie B; Kwak LW
    Bone Marrow Transplant; 2005 Aug; 36(4):315-23. PubMed ID: 15968284
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enhanced antitumoral effectiveness of idiotype vaccination induced by the administration of Flt3 ligand combined with interleukin 2 against a murine myeloma.
    Zeis M; Zunkel T; Steinmann J; Schmitz N; Uharek L
    Br J Haematol; 2002 Apr; 117(1):93-102. PubMed ID: 11918538
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Idiotypic vaccination as therapy for multiple myeloma.
    Kwak LW; Thielemans K; Massaia M
    Semin Hematol; 1999 Jan; 36(1 Suppl 3):34-7. PubMed ID: 9989488
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Detection of CD4 T-cell responses to a tumor vaccine by cytokine flow cytometry.
    Maecker HT; Auffermann-Gretzinger S; Nomura LE; Liso A; Czerwinski DK; Levy R
    Clin Cancer Res; 2001 Mar; 7(3 Suppl):902s-908s. PubMed ID: 11300490
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tumor vaccination strategies combined with autologous peripheral stem cell transplantation.
    Kwak LW
    Ann Oncol; 1998; 9 Suppl 1():S41-6. PubMed ID: 9581240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.